Proceedings of the National Academy of Sciences · 2021 · 75 citations · 42 references
Life SciencesImmunologyNeurologyAutoimmunityInflammationNeuroimmunologyAutoimmune Neurological DisordersCentral Nervous System ImmunityHelper T Cell SubsetsImmune-mediated Inflammatory DiseasesMultiple SclerosisNeuroinflammationCd4 Positive T CellsImmune-mediated PathogenesisInflammatory Tissue DamageMultiple Sclerosis ImmunopathogenesisMultiple Sclerosis ImmunopathologyRelapsing Disease CourseT Cell-mediated InflammationT-cell Mediated Inflammation
Significance Multiple sclerosis (MS) can transition from a relapsing-remitting form (RRMS) into a chronic progressive form (secondary progressive MS, SPMS). SPMS pathogenesis remains poorly understood with diagnosis based entirely on retrospective clinical monitoring. We show that T helper cells expressing the transcription factor Eomes (Eomes + Th cells) were significantly increased in peripheral blood from SPMS patients versus healthy subjects or RRMS and other progressive MS patients. Moreover, Eomes + Th cells expressing granzyme B were found infiltrating brain tissues in SPMS autopsy samples, providing support for a pathogenic role. Analysis of clinical status on follow-up indicated the value of measuring Eomes + Th cells for SPMS diagnosis and prognostic monitoring. This study may contribute to future development of biomarker-assisted “precision medicine” for MS.
42
Rating neurologic impairment in multiple sclerosis
John F. Kurtzke · Neurology · 1983 · 14.9K citations
Alastair Compston, Alasdair Coles · The Lancet · 2008 · 4.3K citations
Defining the clinical course of multiple sclerosis
Fred Lublin, Stephen C. Reingold · Neurology · 1996 · 3.7K citations
Defining the clinical course of multiple sclerosis
Fred Lublin, Stephen C. Reingold, Jeffrey A. Cohen et al. · Neurology · 2014 · 3.1K citations · Full text